Anders D. Hove, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 224,833 shares at $70.33 ($16.0M) on 2016-04-07, disclosed to the SEC on 2016-04-11.
Open-market sale of $16.0M ANAC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.33 | 102,760 | $7.2M | 45.2% |
| 2 | $71.44 | 99,981 | $7.1M | 44.7% |
| 3 | $72.15 | 13,000 | $938K | 5.9% |
| 4 | $73.29 | 2,272 | $167K | 1.0% |
| 5 | $75.57 | 6,820 | $515K | 3.2% |
| Total | $71.12 avg | 224,833 |
| $16.0M |
| 100% |
| Filing → |
| ANAC | SELL | 2016-04-11 | $8.8M | — | Filing → |
| ANAC | SELL | 2016-04-11 | $16.3M | — | Filing → |
| ANAC | SELL | 2015-12-17 | $100.1M | — | Filing → |